Fol. Biol. 2026, 72, 109-117
https://doi.org/10.14712/fb2026.0011
Correlation between circ_0092576 and Arterial Stenosis Severity and Inflammatory Status in Patients with Coronary Heart Disease and Its Clinical Value
Wenqin Dai1
, Lingli Wang2, Yuan Li3, Li Liu3, Peng Chen4
, Lingli Wang2, Yuan Li3, Li Liu3, Peng Chen4
1Department of Cardiology, Wuhan Wuchang Hospital, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, 430063, Hubei, China
2Department of Cardiology, Shanghai 8th People’s Hospital, Shanghai, China
3Department of General Practice, Chinese and Western Medicine Hospital of Panzhihua, Panzhihua, Sichuan, China
4Department of Interventional Medicine, People’s Hospital of Jiulongpo District, Chongqing, 400050, China
Received November 6, 2025
Accepted March 17, 2026
References
1. , P. A., Gaalema, D. E. (2012) Coronary heart disease as a case study in prevention: potential role of incentives. Prev. Med. 55 (Suppl.), S75-S79.
<https://doi.org/10.1016/j.ypmed.2011.12.025>
2. , P., Tsai, M. C., Meylan, C. et al. (2023) Comparison of acceleration-speed profiles from training and competition to individual maximal sprint efforts. J. Biomech. 157, 111724.
<https://doi.org/10.1016/j.jbiomech.2023.111724>
3. , P., Tran, C., Dinh, T. et al. (2024) Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1. J. Biomol. Struct. Dyn. 42, 5114-5127.
<https://doi.org/10.1080/07391102.2023.2225109>
4. , E. (2002) Hypertension and coronary heart disease. J. Hum. Hypertens. 16 (Suppl. 1), S61-S63.
<https://doi.org/10.1038/sj.jhh.1001345>
5. , Z., Yuan, X., Yuan, Y. (2025) Circular RNAs in coronary heart disease: from molecular mechanism to promising clinical application (Review). Int. J. Mol. Med. 55, 11.
<https://doi.org/10.3892/ijmm.2024.5452>
6. , S. A., Newby, L. K. (2009) Prognostic biomarkers in individuals with prevalent coronary heart disease. Dis. Markers 26, 265-271.
<https://doi.org/10.1155/2009/854193>
7. , K., Brany, D., Dvorská, D. et al. (2025) Dysregulated miR-1246 and miR-1253 link inflammatory protein markers in plasma to major depressive disorder in female adolescents. Brain Behav. Immun. Health 49, 101108.
<https://doi.org/10.1016/j.bbih.2025.101108>
8. , H., Devi, N., Siwal, S. S. et al. (2023) Metal-organic framework-based materials for wastewater treatment: superior adsorbent materials for the removal of hazardous pollutants. ACS Omega 8, 9004-9030.
<https://doi.org/10.1021/acsomega.2c07719>
9. , M. Z., Zhang, J. N., Ren, F. et al. (2023) Diagnostic value of circRNA in coronary heart disease: a meta-analysis. Biomark. Med. 17, 667-677.
<https://doi.org/10.2217/bmm-2023-0369>
10. , W., Zuo, M., Zhao, H. et al. (2022) Prediction of coronary heart disease based on combined reinforcement multitask progressive time-series networks. Methods 198, 96-106.
<https://doi.org/10.1016/j.ymeth.2021.12.009>
11. , F., Liu, L., Feng, Q. et al. (2021) Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease. J. Clin. Lab. Anal. 35, e23593.
<https://doi.org/10.1002/jcla.23593>
12. , M., Liao, L., Deng, Y. et al. (2023) Risk factors for inspiratory muscle weakness in coronary heart disease. Heart Lung 60, 35-38.
<https://doi.org/10.1016/j.hrtlng.2023.02.019>
13. , J., Li, K. (2023) Systemic immune-inflammation index is associated with coronary heart disease: a cross-sectional study of NHANES 2009-2018. Front. Cardiovasc. Med. 10, 1199433.
<https://doi.org/10.3389/fcvm.2023.1199433>
14. , M., Hamer, O., Walker, E. et al. (2022) Antibiotics for the secondary prevention of coronary heart disease. Br. J. Card. Nur. 17, 1-7.
<https://doi.org/10.12968/bjca.2022.0082>
15. , X., Chen, S. Y. (2022) Circular RNAs in cardiovascular diseases. Pharmacol. Ther. 232, 107991.
<https://doi.org/10.1016/j.pharmthera.2021.107991>
16. , Y., Xue, Z., Qu, S. et al. (2023) The economic burden of coronary heart disease in mainland China. Public Health 224, 140-151.
<https://doi.org/10.1016/j.puhe.2023.08.034>
17. , R. Y., Zhao, C. H., Yuan, J. X. et al. (2019) Circular RNA profile in coronary artery disease. Am. J. Transl. Res. 11, 7115-7125.
18. , Z., Lv, J., Zhao, L. et al. (2024) CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages. Cardiovasc. Res. 120, 1531-1549.
<https://doi.org/10.1093/cvr/cvae148>
19. , M., Dandare, A., Javed, A. et al. (2023) Competing endogenous RNA regulatory networks of hsa_circ_0126672 in pathophysiology of coronary heart disease. Genes (Basel) 14, 550.
<https://doi.org/10.3390/genes14030550>
20. , P. H., Libby, P., Boden, W. E. (2023) Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management – the plaque hypothesis: a narrative review. JAMA Cardiol. 8, 192-201.
<https://doi.org/10.1001/jamacardio.2022.3926>
21. , A., Bronisz, A., Godlewski, J. (2023) Circular RNAs - new kids on the block in cancer pathophysiology and management. Cells 12, 552.
<https://doi.org/10.3390/cells12040552>
22. , M., Kuhlmann, S. L., Rieckmann, N. et al. (2021) Brain-derived neurotrophic factor, depressive symptoms and somatic comorbidity in patients with coronary heart disease. Acta Neuropsychiatr. 33, 22-30.
<https://doi.org/10.1017/neu.2020.31>
23. , Y., Zhuang, Y., Lin, C. et al. (2024) The neutrophil-to-lymphocyte ratio is associated with coronary heart disease risk in adults: a population-based study. PLoS One 19, e0296838.
<https://doi.org/10.1371/journal.pone.0296838>
24. , Y. Q., Xu, Z. M., Wang, X. L. et al. (2020) LncRNA FOXC2-AS1 regulated proliferation and apoptosis of vascular smooth muscle cell through targeting miR-1253/FOXF1 axis in atherosclerosis. Eur. Rev. Med. Pharmacol. Sci. 24, 3302-3314.
25. , L., Liu, L., Bai, M. et al. (2023) CircRNAs: versatile players and new targets in organ fibrosis. Cell Commun. Signal. 21, 90.
<https://doi.org/10.1186/s12964-023-01051-1>
26. , Q., Li, F., He, A. T. et al. (2021) Circular RNAs: expression, localization, and therapeutic potentials. Mol. Ther. 29, 1683-1702.
<https://doi.org/10.1016/j.ymthe.2021.01.018>
27. , D., Jiaheng, Z., Yili, X. et al. (2025) CircRNA: a new target for ischemic stroke. Gene 933, 148941.
<https://doi.org/10.1016/j.gene.2024.148941>
28. , W., Cui, J., Li, L. et al. (2024a) Identification of plasma exosomes hsa_circ_0001360 and hsa_circ_0000038 as key biomarkers of coronary heart disease. Cardiol. Res. Pract. 2024, 5557143.
29. , Y., Qi, X., Wang, S. et al. (2024b) Serum immunoglobulin M is associated with the severity of coronary artery disease in adults. PeerJ 12, e17012.
<https://doi.org/10.7717/peerj.17012>
30. , W. Y., Cai, Z. R., Liu, J. et al. (2020) Circular RNA: metabolism, functions and interactions with proteins. Mol. Cancer 19, 172.
<https://doi.org/10.1186/s12943-020-01286-3>
